SaxoCell aims to develop new areas of application and production methods for personalized gene and cell therapeutics, so-called »living drugs«. The aim is to produce cells with precisely defined functions and a high safety profile for safe, clinical use on an industrial scale and at socially acceptable costs in order to enable a realistic and sustainable economic model with high value-added potential for the region.
In order to achieve this aim, four of the best research institutions in Saxony have joined forces:
Fraunhofer Institute for Cell Therapy and Immunology
Cluster4Future Innovation Competition
SaxoCell is one of the winners of the innovation competition “Clusters4Future” of the Federal Ministry of Education and Research (BMBF). Our concept for a Saxon future cluster SaxoCell in the promising field of cell and gene therapy was selected by an expert jury together with six other projects from a total of 137 applicants in the first competition phase.